AAAAAA

   
Results: 1-25 | 26-49 |
Results: 26-49/49
Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?
Authors: Shamash, J O'Doherty, CA Oliver, RTD Kelsey, S Gupta, RK Gallagher, CJ Newland, AC Lister, TA
Citation: J. Shamash et al., Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?, ACTA ONCOL, 39(7), 2000, pp. 857-863
An early-time infrared and optical study of the Type Ia Supernova 1998bu in M96
Authors: Hernandez, M Meikle, WPS Aparicio, A Benn, CR Burleigh, MR Chrysostomou, AC Fernandes, AJL Geballe, TR Hammersley, PL Iglesias-Paramo, J James, DJ James, PA Kemp, SN Lister, TA Martinez-Delgado, D Oscoz, A Pollacco, DL Rozas, M Smartt, SJ Sorensen, P Swaters, RA Telting, JH Vacca, WD Walton, NA Zapatero-Osorio, MR
Citation: M. Hernandez et al., An early-time infrared and optical study of the Type Ia Supernova 1998bu in M96, M NOT R AST, 319(1), 2000, pp. 223-234
A photometric study of the contact binaries V523 Cas and TY UMa
Authors: Lister, TA McDermid, RM Hilditch, RW
Citation: Ta. Lister et al., A photometric study of the contact binaries V523 Cas and TY UMa, M NOT R AST, 317(1), 2000, pp. 111-119
The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma
Authors: Goff, LK Neat, MJ Crawley, CR Jones, L Jones, E Lister, TA Gupta, RK
Citation: Lk. Goff et al., The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma, BR J HAEM, 111(2), 2000, pp. 618-625
Familial follicular lymphoma: A case report with molecular analysis
Authors: Last, KW Goff, LK Summers, KE Neat, M Jenner, M Crawley, C Rohatiner, AZ Fitzgibbon, J Lister, TA
Citation: Kw. Last et al., Familial follicular lymphoma: A case report with molecular analysis, BR J HAEM, 110(3), 2000, pp. 744-745
A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response
Authors: Foran, JM Gupta, RK Cunningham, D Popescu, RA Goldstone, AH Sweetenham, JW Pettengell, R Johnson, PWM Bessell, E Hancock, B Summers, K Hughes, J Rohatiner, AZS Lister, TA
Citation: Jm. Foran et al., A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response, BR J HAEM, 109(1), 2000, pp. 81-88
Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy
Authors: Shamash, J Oliver, RTD Gallagher, CJ Newland, AC Lister, TA Kelsey, S Gupta, RK O'Doherty, CA
Citation: J. Shamash et al., Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy, BR J CANC, 82(12), 2000, pp. 2022-2023
More about: B-cell non-Hodgkin's lymphoma: Evidence for the t(14;18) translocation in all hematopoietic cell lineages
Authors: Apostolidis, J Lillington, DM Goff, LK Jones, EL Lister, TA Gupta, RK
Citation: J. Apostolidis et al., More about: B-cell non-Hodgkin's lymphoma: Evidence for the t(14;18) translocation in all hematopoietic cell lineages, J NAT CANC, 91(19), 1999, pp. 1687-1688
Acute promyelocytic leukaemia: a retrospective analysis of patients treated at St. Bartholomew's Hospital 1969-1995
Authors: Slater, S Carter, M Howe, K Amess, J Rohatiner, AZS Lister, TA
Citation: S. Slater et al., Acute promyelocytic leukaemia: a retrospective analysis of patients treated at St. Bartholomew's Hospital 1969-1995, ANN HEMATOL, 78(3), 1999, pp. 131-137
CT appearances of mucosa-associated lymphoid tissue (MALT) lymphoma
Authors: Kessar, P Norton, A Rohatiner, AZS Lister, TA Reznek, RH
Citation: P. Kessar et al., CT appearances of mucosa-associated lymphoid tissue (MALT) lymphoma, EUR RADIOL, 9(4), 1999, pp. 693-696
The World Health Organization classification of neoplastic diseases of thehematopoietic and lymphoid tissues
Authors: Harris, NL Jaffe, ES Diebold, J Flandrin, G Muller-Hermelink, HK Vardiman, J Lister, TA Bloomfield, CD
Citation: Nl. Harris et al., The World Health Organization classification of neoplastic diseases of thehematopoietic and lymphoid tissues, ANN ONCOL, 10(12), 1999, pp. 1419-1432
Immunocytoma: A retrospective analysis from St Bartholomew's Hospital - 1972 to 1996
Authors: Papamichael, D Norton, AJ Foran, JM Mulatero, C Mathews, J Amess, JAL Bradburn, M Lister, TA Rohatiner, AZS
Citation: D. Papamichael et al., Immunocytoma: A retrospective analysis from St Bartholomew's Hospital - 1972 to 1996, J CL ONCOL, 17(9), 1999, pp. 2847-2853
Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia
Authors: Foran, JM Oscier, D Orchard, J Johnson, SA Tighe, M Cullen, MH de Takats, PG Kraus, C Klein, M Lister, TA
Citation: Jm. Foran et al., Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia, J CL ONCOL, 17(5), 1999, pp. 1574-1579
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
Authors: Cheson, BD Horning, SJ Coiffier, B Shipp, MA Fisher, RI Connors, JM Lister, TA Vose, J Grillo-Lopez, A Hagenbeek, A Cabanillas, F Klippensten, D Hiddemann, W Castellino, R Harris, NL Armitage, JO Carter, W Hoppe, R Canellos, GP
Citation: Bd. Cheson et al., Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas, J CL ONCOL, 17(4), 1999, pp. 1244-1253
Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstrom's macroglobulinemia, and mantle-cell lymphoma
Authors: Foran, JM Rohatiner, AZS Coiffier, B Barbui, T Johnson, SA Hiddemann, W Radford, JA Norton, AJ Tollerfield, SM Wilson, MP Lister, TA
Citation: Jm. Foran et al., Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstrom's macroglobulinemia, and mantle-cell lymphoma, J CL ONCOL, 17(2), 1999, pp. 546-553
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997
Authors: Harris, NL Jaffe, ES Diebold, J Flandrin, G Muller-Hermelink, HK Vardiman, J Lister, TA Bloomfield, CD
Citation: Nl. Harris et al., World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997, J CL ONCOL, 17(12), 1999, pp. 3835-3849
Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma
Authors: Apostolidis, J Foran, JM Johnson, PWM Norton, A Amess, J Matthews, J Bradburn, M Lister, TA Rohatiner, AZS
Citation: J. Apostolidis et al., Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma, J CL ONCOL, 17(1), 1999, pp. 216-221
Doppler imaging of BD+22 degrees 4409 (LO Peg) using least-squares deconvolution
Authors: Lister, TA Cameron, AC Bartus, J
Citation: Ta. Lister et al., Doppler imaging of BD+22 degrees 4409 (LO Peg) using least-squares deconvolution, M NOT R AST, 307(3), 1999, pp. 685-694
Asymptomatic carotid arterial disease in young patients following neck radiation therapy for Hodgkin lymphoma
Authors: King, LJ Hasnain, SN Webb, JAW Kingston, JE Shafford, EA Lister, TA Shamash, J Reznek, RH
Citation: Lj. King et al., Asymptomatic carotid arterial disease in young patients following neck radiation therapy for Hodgkin lymphoma, RADIOLOGY, 213(1), 1999, pp. 167-172
Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma
Authors: Fitzgibbon, J Grenzelias, D Matthews, J Lister, TA Gupta, RK
Citation: J. Fitzgibbon et al., Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma, BR J HAEM, 107(2), 1999, pp. 388-391
Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy
Authors: Jenkins, PJ Sohaib, SA Trainer, PJ Lister, TA Besser, GM Reznek, R
Citation: Pj. Jenkins et al., Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy, BR J CANC, 80(11), 1999, pp. 1815-1819
Peripheral T-cell lymphoma following Rituximab therapy for B-cell lymphoma
Authors: Micallef, INM Kirk, A Norton, A Foran, JM Rohatiner, AZS Lister, TA
Citation: Inm. Micallef et al., Peripheral T-cell lymphoma following Rituximab therapy for B-cell lymphoma, BLOOD, 93(7), 1999, pp. 2427-2428
Clinical evaluation and staging of Hodgkin's disease
Authors: Gupta, RK Gospodarowicz, MK Lister, TA
Citation: Rk. Gupta et al., Clinical evaluation and staging of Hodgkin's disease, HODGKIN'S DISEASE, 1999, pp. 223-240
Mantle cell lymphomas (MCL) - Biologic and clinical characterization and prospective evaluation of myeloablative radio-chemotherapy with blood stem cell transplantation
Authors: Hiddemann, W",Parwaresch,"Stein, H Pedrinis, E Berger, F Peeters, C Norton, A Coiffier, B VanHoof, A",Cavalli,"Brittinger, G Lister, TA
Citation: H. Hiddemann, W",parwaresch,"stein et al., Mantle cell lymphomas (MCL) - Biologic and clinical characterization and prospective evaluation of myeloablative radio-chemotherapy with blood stem cell transplantation, BIOM HLTH R, 24, 1998, pp. 82-89
Risultati: 1-25 | 26-49 |